Logo image of XBP

XBP GLOBAL HOLDINGS INC (XBP) Stock Fundamental Analysis

NASDAQ:XBP - US98400V1017 - Common Stock

0.5948 USD
-0.03 (-4.06%)
Last: 8/22/2025, 2:29:57 PM
Fundamental Rating

1

We assign a fundamental rating of 1 out of 10 to XBP. XBP was compared to 100 industry peers in the Financial Services industry. XBP has a bad profitability rating. Also its financial health evaluation is rather negative. XBP has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

XBP had negative earnings in the past year.
XBP had a negative operating cash flow in the past year.
In the past 5 years XBP reported 4 times negative net income.
In the past 5 years XBP always reported negative operating cash flow.
XBP Yearly Net Income VS EBIT VS OCF VS FCFXBP Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 0 -5M -10M

1.2 Ratios

The Return On Assets of XBP (-14.66%) is worse than 90.00% of its industry peers.
Industry RankSector Rank
ROA -14.66%
ROE N/A
ROIC N/A
ROA(3y)-5.75%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
XBP Yearly ROA, ROE, ROICXBP Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 0 20 40 60 80

1.3 Margins

XBP has a Gross Margin of 27.32%. This is comparable to the rest of the industry: XBP outperforms 45.00% of its industry peers.
The Profit Margin and Operating Margin are not available for XBP so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 27.32%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
XBP Yearly Profit, Operating, Gross MarginsXBP Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 0 10 20

More info and screens

1

2. Health

2.1 Basic Checks

XBP does not have a ROIC to compare to the WACC, probably because it is not profitable.
XBP has about the same amout of shares outstanding than it did 1 year ago.
XBP has a worse debt/assets ratio than last year.
XBP Yearly Shares OutstandingXBP Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 10M 20M 30M
XBP Yearly Total Debt VS Total AssetsXBP Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

2.2 Solvency

XBP has an Altman-Z score of 1.04. This is a bad value and indicates that XBP is not financially healthy and even has some risk of bankruptcy.
XBP has a better Altman-Z score (1.04) than 62.00% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z 1.04
ROIC/WACCN/A
WACC9.83%
XBP Yearly LT Debt VS Equity VS FCFXBP Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 0 50M 100M 150M 200M

2.3 Liquidity

A Current Ratio of 0.61 indicates that XBP may have some problems paying its short term obligations.
XBP has a worse Current ratio (0.61) than 60.00% of its industry peers.
A Quick Ratio of 0.56 indicates that XBP may have some problems paying its short term obligations.
Looking at the Quick ratio, with a value of 0.56, XBP is doing worse than 63.00% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.61
Quick Ratio 0.56
XBP Yearly Current Assets VS Current LiabilitesXBP Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 20M 40M 60M 80M

More info and screens

1

3. Growth

3.1 Past

XBP shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 82.92%, which is quite impressive.
The Revenue has grown by 77.86% in the past year. This is a very strong growth!
EPS 1Y (TTM)82.92%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-70.49%
Revenue 1Y (TTM)77.86%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-6.63%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
XBP Yearly Revenue VS EstimatesXBP Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2023 2024 50M 100M 150M

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

XBP reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
XBP Price Earnings VS Forward Price EarningsXBP Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, XBP is valued a bit more expensive than the industry average as 60.00% of the companies are valued more cheaply.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 34.24
XBP Per share dataXBP EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

XBP does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

XBP GLOBAL HOLDINGS INC

NASDAQ:XBP (8/22/2025, 2:29:57 PM)

0.5948

-0.03 (-4.06%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryFinancial Services
Earnings (Last)08-18 2025-08-18
Earnings (Next)11-12 2025-11-12
Inst Owners19.3%
Inst Owner Change-1.84%
Ins Owners10.46%
Ins Owner Change0%
Market Cap69.90M
AnalystsN/A
Price TargetN/A
Short Float %2.27%
Short Ratio0.53
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.48
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA 34.24
EPS(TTM)-0.45
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.04
FCFYN/A
OCF(TTM)-0.02
OCFYN/A
SpS1.23
BVpS-0.17
TBVpS-0.38
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -14.66%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 27.32%
FCFM N/A
ROA(3y)-5.75%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover1.46
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA 8.95
Cap/Depr 70.71%
Cap/Sales 1.67%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.61
Quick Ratio 0.56
Altman-Z 1.04
F-Score4
WACC9.83%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)82.92%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-70.49%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)77.86%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-6.63%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y84.57%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-79.48%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-240.52%
OCF growth 3YN/A
OCF growth 5YN/A